FDA recall records

Code-Snippets

curl "https://api.oanor.com/drug-api/v1/recalls" \
  -H "x-oanor-key: oanor_test_..."

await fetch("https://api.oanor.com/drug-api/v1/recalls", {
  headers: { "x-oanor-key": "oanor_test_..." }
});

$ch = curl_init("https://api.oanor.com/drug-api/v1/recalls");
curl_setopt($ch, CURLOPT_HTTPHEADER, ["x-oanor-key: oanor_test_..."]);
curl_setopt($ch, CURLOPT_RETURNTRANSFER, true);
$out = curl_exec($ch);

import requests
requests.get(
    "https://api.oanor.com/drug-api/v1/recalls",
    headers={"x-oanor-key": "oanor_test_..."}
)

Beispiel-Response

Echte Antwort dieses Endpoints, erfasst beim letzten Health-Check.

{
    "data": {
        "drug": "valsartan",
        "count": 10,
        "results": [
            {
                "reason": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.",
                "status": "Ongoing",
                "company": "Mylan Laboratories Limited, (Nashik FDF)",
                "country": "India",
                "product": "Valsartan and Hydrochlorothiazide Tablets, USP 320/25 mg, (a) 90-count bottle (NDC 0378-6325-77), (b) 500-count bottles (NDC 0378-6325-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.",
                "recall_date": "20181204",
                "distribution": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.",
                "classification": "Class II"
            },
            {
                "reason": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.",
                "status": "Ongoing",
                "company": "Mylan Laboratories Limited, (Nashik FDF)",
                "country": "India",
                "product": "Valsartan and Hydrochlorothiazide Tablets, USP 160/25 mg, (a) 90-count bottle (NDC 0378-6323-77), (b) 500-count bottles (NDC 0378-6323-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.",
                "recall_date": "20181204",
                "distribution": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.",
                "classification": "Class II"
            },
            {
                "reason": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.",
                "status": "Ongoing",
                "company": "Mylan Laboratories Limited, (Nashik FDF)",
                "country": "India",
                "product": "Valsartan and Hydrochlorothiazide Tablets, USP 160/12.5 mg, (a) 90-count bottle (NDC 0378-6322-77), (b) 500-count bottles (NDC 0378-6322-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.",
                "recall_date": "20181204",
                "distribution": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.",
                "classification": "Class II"
            },
            {
                "reason": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.",
                "status": "Ongoing",
                "company": "Prinston Pharmaceutical Inc",
                "country": "United States",
                "product": "Solco Healthcare US Valsarta
…